Table: begin end state 1 6 cytoplasmic 7 33 transmembrane 34 52 non-cytoplasmic 53 73 transmembrane 74 130 cytoplasmic 131 153 transmembrane 154 168 non-cytoplasmic 169 191 transmembrane 192 212 cytoplasmic 213 234 transmembrane 235 239 non-cytoplasmic 240 257 transmembrane 258 263 cytoplasmic 264 289 transmembrane 290 303 non-cytoplasmic 304 327 transmembrane 328 331 cytoplasmic 332 351 transmembrane 352 356 non-cytoplasmic 357 385 transmembrane 386 396 cytoplasmic 397 416 transmembrane 417 419 non-cytoplasmic
Input: >SMc00273 FitnessBrowser__Smeli:SMc00273 MTAIMTGLFAALLAISVPVGYALIIAAGAAILWQGGTPTVLAVVKLFQPTQSFPLLAIPF FILSGSLMMSGTLGQKLVQFAAALVGRFHGGMGQVTVVGSTIFGGVSGSAVAEASALGSM LIPWQKKEGYPAGFAAAVTASSSTIAGLIPPSIPLILFSTVANSSIASLFSAAVLPGLML AGGMMIVCYLSGRIRNFPRLTDAGQLKSFGRSMLSALPALAMPFFIILLLRAGIATPTEV SVIAVFYALLVSLLLYRDLTWERIYAALVGTVITTGVVMLVIAASSLVGHVLITERVPTI VANWALETLGSAILIILMMNLIMLVVGMFLDLPAAILLLGPTFVAIGHAIGMDPIQLGVM ICINLSIGLFTPPIGTTLFIGAVIARVPIGAVVKELWPFYIVAAAVLVLMSYVPALTIY
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server